Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |